Sociodemographic and neurological details of 43 patients included in the study
| *No patient was diagnosed with SMS and myoclonus (jerking SMS6). | |
| AMP, amphiphysin; GAD, glutamic acid decarboxylase; PERM, progressive encephalomyelitis with rigidity and myoclonus; pSMS, paraneoplastic stiff man syndrome; SLS, stiff leg syndrome; SMS, stiff man syndrome. | |
| Total number | 43 |
| Male (n (%)) | 14 (32.6) |
| Female (n (%)) | 29 (67.4) |
| Age (years) | |
| Range | 18 to 75 |
| Mean (SD) | 52.9 (13.8) |
| Duration of disease (years) | |
| Range | 0.5 to 35 |
| Mean (SD) | 7.8 (7.5) |
| Type of disease* (n (%)) | |
| SMS | 22 (51.2) |
| PERM | 15 (34.9) |
| SLS | 3 (7.0) |
| pSMS | 3 (7.0) |
| Antibody status (n (%)) | |
| AntiGAD positive | 30 (69.8) |
| AntiAMP positive | 2 (4.7) |
| AntiGAD/AMP negative | 11 (25.6) |
| Task specific phobia (n (%)) | |
| Present | 19 (44.2) |
| Phobic anxiety w/o avoidance | 3 (7.0) |
| Absent | 21 (48.8) |